Stock 8MV0 BIOHARVEST SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BioHarvest Sciences Inc. Deutsche Boerse AG

Equities

8MV0

CA09076J2074

Food Processing

Market Closed - Deutsche Boerse AG
Other stock markets
 02:10:55 2024-07-16 am EDT 		5-day change 1st Jan Change
5.5 EUR -0.36% Intraday chart for BioHarvest Sciences Inc. +3.77% +13.05%
Jun. 28 BioHarvest Sciences Raises US$4.3 Million in First Tranche of Financing, Reports Debt Notes Conversion MT
Jun. 21 BioHarvest Sciences Announces US$5 Million Private-Placement Financing, Conversion of Debt Notes MT

Valuation

Fiscal Period: December 2020 2024 2025 2026
Capitalization 1 78.51 107.6 - -
Enterprise Value (EV) 1 78.51 107.6 107.6 107.6
P/E ratio -11.3 x - - -
Yield - - - -
Capitalization / Revenue - 4.23 x 1.6 x 1.08 x
EV / Revenue - 4.23 x 1.6 x 1.08 x
EV / EBITDA - -42.6 x 17.7 x 7.71 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - - -
Nbr of stocks (in thousands) 12,699 17,328 - -
Reference price 2 7.875 8.500 8.500 8.500
Announcement Date 4/29/21 - - -
1CAD in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2024 2025 2026
Net sales 1 - 25.42 67.31 99.8
EBITDA 1 - -2.523 6.094 13.96
EBIT 1 - -3.685 4.004 10.7
Operating Margin - -14.5% 5.95% 10.72%
Earnings before Tax (EBT) - - - -
Net income -6.584 - - -
Net margin - - - -
EPS -0.7000 - - -
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 4/29/21 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 5.97 6.69 7.41 9.26 12.49
EBITDA - - - - -
EBIT - - - - -
Operating Margin - - - - -
Earnings before Tax (EBT) - - - - -
Net income - - - - -
Net margin - - - - -
EPS - - - - -
Dividend per Share - - - - -
Announcement Date - - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2024 2025 2026
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex - - - -
Capex / Sales - - - -
Announcement Date 4/29/21 - - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+21.64% 8.68B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
-6.80% 6.71B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
-16.77% 4.97B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-6.11% 3.66B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-22.96% 3.08B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-18.62% 1.13B
HERBALIFE LTD. Stock Herbalife Ltd.
-25.62% 1.13B
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-1.51% 953M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-11.94% 862M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. BHSC Stock
  4. 8MV0 Stock
  5. Financials BioHarvest Sciences Inc.